Blut

  • Karl-Heinz Huhnstock
  • Werner Kutscha

Zusammenfassung

Die Anämie als allgemein klinischer Befund muß näher erläutert werden. Zur Abklärung ihrer Ursache erfordert sie gelegentlich ausführliche Untersuchungen. Die Beantwortung folgender 4 Fragen gestattet meistens die Beurteilung eines anämischen Patienten:
  1. 1.

    besteht ein Eisenmangel,

     
  2. 2.

    handelt es sich um eine megaloblastische (hyperchrome) Anämie,

     
  3. 3.

    findet sich eine Hämolyse oder läßt sich

     
  4. 4.

    eine Knochenmarksinsuffizienz nachweisen?

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur

  1. Committee on Iron Deficiency: Iron Deficiency in the United States. Jama 203, 407–412 (1968).CrossRefGoogle Scholar
  2. Kasper, C. K., Whissell, D. Y. E., Wallerstein, R. O.: Clinical aspects of iron deficiency. Jama 191, 359–363 (1965).PubMedCrossRefGoogle Scholar
  3. Castle, W. B.: Current concept of pernicious anemia. Amer. J. Med. 48, 541–548 (1970).PubMedCrossRefGoogle Scholar
  4. Heinrich, H. C.: Metabolie basis of the diagnosis and therapy in vitamine B12 deficiency. Pages 199–249 in: Seminars in hematology, vol. 1. Grüne and Stratton 1964.Google Scholar
  5. Herbert, V.: Megaloblastic anemia. New Engl. J. Med. 268, 201–203, 368–371 (1963).Google Scholar
  6. Lewis, S. M.: Course and prognosis in aplastic anemia. Brit. med. J. 1965 I, 1027–1030.CrossRefGoogle Scholar
  7. Byers, R. K.: Lead poisening. Review of the literature and report on 45 cases. Pediatrics 23, 585–603 (1959).PubMedGoogle Scholar
  8. Tudhope, J. R.: Anemia in hypothyreodism. Quart. J. Med. 29, 513 (1960).PubMedGoogle Scholar
  9. Finkel, H. E., Kimber, R. J., Damashek W.: Corticosteroid-responsive acquired pure red cell aplasia in adults. Amer. J. Med. 43, 771 bis 776 (1967).Google Scholar
  10. Tsai, S. Y., Levin W. C.: Chronic erythroeytic hypoplasia in adults. Review of the literature and report of a case. Amer. J. Med. 22, 322–330 (1957).PubMedCrossRefGoogle Scholar
  11. Allgood, J. W., Chaplin, H.: Idiopathic acquired autoimmune hemolytic anemia. Amer. J. Med. 43, 254–273 (1967).PubMedCrossRefGoogle Scholar
  12. Dacie, J. V.: Autoimmune hemolytic anemia. Brit. med. J. 1970 II, 381–386.CrossRefGoogle Scholar
  13. Jacob, H. S.: Abnormality in the physiology of the erythrocyte membrane in hereditary spherocytosis. Amer. J. Med. 41, 734–74: (1966).PubMedCrossRefGoogle Scholar
  14. Cutting, H. O. et al.: Autosomal dominant hemolytic anemia characterized by ovalocytosis. Amer. J. Med. 39, 21–34 (1965).PubMedCrossRefGoogle Scholar
  15. Geerdink, R. A. et al.: Hereditary spherocytosis and hyperhemolysis. Acta med. scand. 179, 715–728 (1966).PubMedCrossRefGoogle Scholar
  16. Wallerstein, R. O., Aggeler, P. M.: Acute hemolytic anemia. Amer. J. Med. 37, 92–104 (1964).PubMedCrossRefGoogle Scholar
  17. Crosby, W. H.: Paroxysmal nocturnal hemoglobinuria. Relation of the clinical mani-festations to underlying pathogenic mecha-nisms. Blood 8, 769–812 (1953).PubMedGoogle Scholar
  18. Hartman, R. C., Jenkins, D. E.: The sugarwater test for paroxysmal nocturnal hemoglobinuria. New Engl. J. Med. 275, 155–157 (1966).Google Scholar
  19. Valentine, W. N.: Hereditary hemolysis ane-mias associated with specific erythrocyte enzymopathies. California Med. 108, 280–294 (1968).PubMedGoogle Scholar
  20. Burka, E. R., Weaver, Z., Marks, P. A.: Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate-dehydrogenase deficiency. Ann. intern. Med. 6, 817–825 (1966).Google Scholar
  21. Carson, P. E., Fisher, H.: G6PD deficiency and related disorders of the pentose phosphate pathway. Amer. J. Med. 41, 744–761 (1966).PubMedCrossRefGoogle Scholar
  22. Grimes, H. J.: Laboratory diagnosis of enzyme defects in the red cell. Brit. J. Hemat. 17, 129–137 (1969).CrossRefGoogle Scholar
  23. Necheles, T. F.: Heinz body anemia. New England J. Med. 280, 203–206 (1969).Google Scholar
  24. Tarlow, A. R. et al.: Primaquine sensitivity. Arch. Int. Med. 109, 209–234 (1962).CrossRefGoogle Scholar
  25. Brain, M. C. et al.: Microangiopathic hemolytic anemia. New Engl. J. Med. 281, 833–835 (1969).Google Scholar
  26. Dacie, J. V. et al.: Refractory normoblastic anemia. Brit. J. Hemat. 5, 56–82 (1959).CrossRefGoogle Scholar
  27. Combined Staff Clinic from Department of Mediane, Columbia University: The thalassaemia Syndrome. Amer. J. Med. 36, 919–935 (1964).CrossRefGoogle Scholar
  28. Ranney, H.: Clinically important variants of human hemoglobin. New Engl. J. Med. 282, 144–152 (1970).Google Scholar
  29. River, G. L., Robbins, A. B., Schwartz, S. O.: S-C hemoglobin: A clinical study. Blood 18, 385–416 (1961).PubMedGoogle Scholar
  30. Aksoy, M.: Alpha S-thalassemia. Blood 22, 757 bis 769 (1963).Google Scholar
  31. Conley, C. L. et al.: Hereditary persistance of the fetal hemoglobin. Blood 21, 261–281 (1963).PubMedGoogle Scholar
  32. Marks, P. A.: Thalassemia syndromes. New Engl. J. Med. 275, 1363–1369 (1966).Google Scholar
  33. Nathan, D. G., Gunn, R. B.: Thalassemia. Amer. J. Med. 41, 815 (1966).PubMedCrossRefGoogle Scholar
  34. Weatherall, D. J.: The Thalassemia Syndromes. Blackwell 1965.Google Scholar
  35. Wai Kan, Y., et al.: Globin diain synthesis in the alpha thalassemia syndromes. J. clin. Invest. 47, 2515–2522 (1968).CrossRefGoogle Scholar
  36. Jandle, J. H., Aster, R. H.: Increased splenic pooling and the pathogenesis of hypersplenism. Am. J. Sc. 253, 383–397 (1967).CrossRefGoogle Scholar
  37. Zieve, L.: Jaundice, hyperlipemia and hemolytic anemia. Ann. intern. Med. 48, 471 (1958).PubMedGoogle Scholar
  38. Hyman, G. A., Harvey, J. L.: The pathogenesis of anemia in patients with carcinoma. Amer. J. Med. 19, 350–356 (1955).PubMedCrossRefGoogle Scholar
  39. Cartwright, G. E., Wintrobe, M. M.: The anemia of infection. XVII. A review. Advanc. intern. Med. 5, 165–226 (1952).Google Scholar
  40. Adamson, J. W., Eschbach, J., Finch, C. A.: The kidney and erythropoisis. AM. J. Med. 44, 725–734 (1967).CrossRefGoogle Scholar
  41. Boggs, D. R., Wintrobe, N. M., Cartwright, G.: The acute leukemias. Medicine 41, 163 - 225 (1962).PubMedCrossRefGoogle Scholar
  42. Damashek, W., et al.: Therapy of acute leukemia. Blood 26, 220 (1965).Google Scholar
  43. Freireich, E. J., Frei, E.: Recent advances in acute leukemia. Pages 187-202 in: Progress in Hematology, Vol. 4, Grüne and Stratton, 1964.Google Scholar
  44. Zuelzer, W. W.: Acute stem cell leukemia. Blood 24, 477–494 (1964).PubMedGoogle Scholar
  45. Haut, A. et al.: Busulfan in the treatment of the chronic myelocytic leukemia. The effect of long term intermittent therapy. Blood 17, 19 (1961).Google Scholar
  46. Haut, A., Wintrobe, M. M., Cartwright, G. E.: The clinical management of leukemia. Amer. J. Med. 28, 777–793 (1960).PubMedCrossRefGoogle Scholar
  47. Boggs, D. E. et al.: Factors influencing the duration of survival of patients with chronic lymphocytic leukemia. Amer. J. Med. 40, 243–254 (1966).PubMedCrossRefGoogle Scholar
  48. Zacharski, L. R., Linman, J. W.: Chronic lymphatic leukemia versus chronic lymphosarkoma cell leukemia. Amer. J. Med. 47, 75 bis 81 (1969).Google Scholar
  49. Mc Callister, B. D. et al.: Primary macroglo- bulinemia. Review with a report on 31 cases and notes on the value of continuous chlorambucil therapy. Amer. J. Med. 43, 394–434 (1967).CrossRefGoogle Scholar
  50. Spalluto, L. O. et al.: Cryoglobulinemia based upon interaction between a gamma macroglo- bulin and 7S gamma globulin. Amer. J. Med. 32, 142–147 (1962).CrossRefGoogle Scholar
  51. Bouroncle, B. A., Doan, C. A.: Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients. Amer. J. med. Sei. 243, 697 bis 715 (1962).Google Scholar
  52. Nakai, G. S. et al.: Agnogenic myeloid metaplasia. Ann. intern. Med. 57, 419–440 (1962).PubMedGoogle Scholar
  53. Aisenberg, A. C.: Primary management of Hodgkin’s disease. New Engl. J. Med. 278, 93–95 (1968).Google Scholar
  54. Kaplan, H. S.: Role of intensive radiotherapy in the management of Hodgkin’s disease. Cancer 19, 356–367 (1966).CrossRefGoogle Scholar
  55. Perry, S. et al.: Hodgkin’s disease. Amer. J. Med. 67, 424–442 (1967).Google Scholar
  56. Kaplan, H. S: Clinical evaluation and radio- therapeutic management of Hodgkin’s disease and the malignant lymphomas. New Engl. J. Med. 278, 892–899 (1968).Google Scholar
  57. Rosenberg, S. A., Diamond, H. D., Craver, L. F.: Lymphosarkoma: The effects of therapy and survival in 1269 patients in a review of 30 years’ experience. Medicine 40, 31–84 (1961).PubMedCrossRefGoogle Scholar
  58. Blumenberg, R. M. et al.: Giant follicular lymphoma — a review of 46 cases. Amer. J. Med. 35, 832–841 (1963).PubMedCrossRefGoogle Scholar
  59. Rappaport, H., Winter, W. J., Hicks, E. W.: Follicular lymphoma. Cancer 9, 792–821 (1956).PubMedCrossRefGoogle Scholar
  60. Block, J. B. et al.: Mycosis fungoides. Amer. J. Med. 34, 228–235 (1963).PubMedCrossRefGoogle Scholar
  61. Gardner, F. (editor): Polycythemia. Seminars in Hematology 3, 175–234 (1966).Google Scholar
  62. Pollycove, M. et al.: Classification and evaluation of patterns of erythropoiesis in polycythemia vera studied by iron kinetics. Blood, 28, 807–829 (1966)PubMedGoogle Scholar
  63. Pisciotta, A. V.: Studies in agranulocytosis: Patterns of recovery. J. Lab. clin. Med. 63, 445 (1964).PubMedGoogle Scholar
  64. Pisciotta, A. V. et al.: Agranulocytosis following administration of phenothiazine derivatives. Amer. J. Med. 25, 210–223 (1958).PubMedCrossRefGoogle Scholar
  65. Gaston, L. W.: The blood clotting factors. New England J. Med. 270, 236–242, 290–298 (1964).Google Scholar
  66. Ratnoff, O. D.: The therapy of the hereditary disorders of blood coagulation. Arch. intern. Med. 112, 92–111 (1963).Google Scholar
  67. Aggeler, P. M. et al.: The mild hemophilias. Occult deficiencies of AHF, PTC and PTA frequently responsible for unexpected surgical bleeding. Amer. J. Med. 30, 89–94 (1961).CrossRefGoogle Scholar
  68. Biggs, R., Mac Farlane, R. G.: Hemophilia and related conditions. A survey of 148 cases. Brit. J. Haemat. 4, 1–27 (1958).PubMedCrossRefGoogle Scholar
  69. Dallmann, P. R., Pool, J. G.: Treatment of hemophilia with factor VIII concentrates. New Engl. J. Med. 278, 199–202 (1968).Google Scholar
  70. Ratnoff, O. D.: The biology and pathology of the initial stages of blood coagulation (factor XII and XI deficiencies). Pages 220–245 in: Progress in Hematology, vol: 5. Grune and Stratton, 1966.Google Scholar
  71. Baldini, M.: Idiopathic thrombocytopenic pur-pura. New Engl. J. Med. 274, 1245–1251, 1301–1306, 1360–1367 (1966).Google Scholar
  72. Doan, C. A., Bouroncle, B. A., Wiseman, B. K.: Idiopathic and secondary thrombocytopenic purpura: Clinical study and evaluation of 381 cases over a period of 28 years. Ann. intern. Med. 53, 861–876 (1960).Google Scholar
  73. Halpern, M., et al.: Hereditary hemorrhagic teleangiectasia. Radiology 90, 1143–1149 (1968).PubMedGoogle Scholar
  74. Amorosi, E. L., Ultmann, J. E.: Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 45, 139–159 (1966).CrossRefGoogle Scholar
  75. Lerner, R. C., Rapaport, S. J., Melitzer, J.: Thrombotic, thrombocytopenic purpura. Serial clotting studies, relation to the generalized Schwartzman reaction, and remission after adrenal steroid and dextran therapy. Ann. intern. Med. 66, 1180–1190 (1967).PubMedGoogle Scholar
  76. Barrow, E. M., Graham, J. B.: Von Wille-brand’s disease. Progr. Hemat. 4, 203–221 (1964).Google Scholar
  77. Caen, J. P.: Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann’s thrombasthenia. Amer. J. Med. 41, 4–26 (1966).Google Scholar
  78. Larrieu, M. J. et al.: Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand’s disease. Amer. J. Med. 45, 354–372 (1968).PubMedCrossRefGoogle Scholar
  79. Sahud, M.: Differential diagnosis of platelet dysfunction. Calif. Med. 112, 66–76 (1970).Google Scholar
  80. Abildgaard, C. F.: Recognition and treatment of intravascular coagulation. J. Pediat. 74, 163–176 (1969).PubMedCrossRefGoogle Scholar
  81. Hammond, O. et al.: Hemolytic-uremic syndrome. Amer. J. Dis. Child. 114, 440–449 (1967).Google Scholar
  82. Rosner, F., Ritz, N. D.: The defibrination syndrome. Arch, intern. Med. 117, 17–24 (1966).Google Scholar
  83. Verstraete, M. et al.: Excessive consumption of blood coagulation components as cause of hemorrhagic diathesis. Amer. J. Med. 38, 899 (1965).PubMedCrossRefGoogle Scholar
  84. O’reilly, R. A., Aggeler, P. M.: Surreptitious ingestion of coumarin anticoagulant drugs. Ann. Intern. Med. 64, 1034–1041 (1966).PubMedGoogle Scholar
  85. Margolius, A. et al.: Circulating anticoagulants. Medicine 40, 145–202 (1961).PubMedCrossRefGoogle Scholar
  86. Aggeler, P. M.: Physiologie basis for transfusion therapy in hemorrhagic disorders. Transfusion 1, 71–86 (1961).PubMedCrossRefGoogle Scholar

Allgemeine Literatur

  1. Biggs, R., Mac Farlane, R. G.: Treatment of Hemophilia and Other Coagulation Disorders. Davis, 1966.Google Scholar
  2. Cartwright, G. E.: Diagnostic Laboratory He-matology, 4th ed. Grune and Stratton, 1967.Google Scholar
  3. Dacie, J. V.: The Hemolytic Anemias. I. Con-genital Hemolytic Anemias. II. The Auto-Immune Hemolytic Anemias. III. Secondary and Symptomatic. IV. Drug-Induced, PNH, He-10. Blutmolytic Disease of the Newborn. Churchill 1960, 1962, 1967.Google Scholar
  4. De Gruchy, G. C: Clinical Hematology in Medical Practice, 2nd ed. Blackwell 1964.Google Scholar
  5. Harris, J. W.: The Red Cell. Production, Me-tabolism, Destruction, Normal and Abnormal. Harvard 1963.Google Scholar
  6. Karnowsky, D. C., Rawson, R. W.: Symposium on medical advances in cancer. M. Clin. North America 50, 611–912 (1966).Google Scholar
  7. Mollison, P. L.: Blood Transfusion in Clinical Medicine, 4th ed. Davis 1967.Google Scholar
  8. Rapaport, H.: Tumors of the Hematopoietic System. Armed Forces Institute of Pathology 1966.Google Scholar
  9. Wintrobe, M. M.: Clinical Hematology, 6th ed. Lea and Febiger 1967.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1973

Authors and Affiliations

  • Karl-Heinz Huhnstock
    • 1
    • 2
  • Werner Kutscha
    • 3
    • 4
  1. 1.Inneren AbteilungSüdwestdeutsches Rehabilitationskrankenhaus Karlsbad-LangensteinbachDeutschland
  2. 2.I. Medizinischen Klinik, Fakultät für klinische Medizin MannheimUniversität HeidelbergDeutschland
  3. 3.Inneren AbteilungVincentius KrankenhausLandauDeutschland
  4. 4.Abteilung für Pathophysiologie an der I. Medizinischen Klinik, Fakultät für klinische Medizin MannheimUniversität HeidelbergDeutschland

Personalised recommendations